Lappersdorf, Germany

Andreas Sellmer

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2018-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Andreas Sellmer: Innovator in Pharmaceutical Chemistry

Introduction

Andreas Sellmer is a notable inventor based in Lappersdorf, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of targeted therapies for various diseases. With a focus on innovative small molecule compounds, Sellmer has been instrumental in advancing medical treatments.

Latest Patents

Sellmer holds 2 patents that showcase his expertise in developing new therapeutic agents. His latest patents include:

1. **Synthesis, pharmacology and use of new and selective FMS-like tyrosine kinase 3 (FLT3) inhibitors** - This invention relates to small molecule compounds designed as FLT3 inhibitors for treating diseases such as acute myeloid leukemia (AML). It also encompasses methods for synthesizing these compounds and their application in treatment.

2. **HDAC6 inhibitors and their uses** - This patent focuses on small molecule compounds that act as HDAC inhibitors, aimed at treating various diseases, including cancer. It further details methods for synthesizing these compounds and their therapeutic applications.

Career Highlights

Throughout his career, Sellmer has worked with prestigious institutions, including the University of Regensburg and Friedrich Schiller University Jena. His work has significantly impacted the field of cancer research and treatment.

Collaborations

Sellmer has collaborated with notable colleagues such as Siavosh Mahboobi and Herwig Pongratz. These partnerships have fostered innovation and contributed to the advancement of pharmaceutical research.

Conclusion

Andreas Sellmer is a distinguished inventor whose work in pharmaceutical chemistry has led to the development of important therapeutic agents. His contributions continue to influence the treatment of serious diseases, showcasing the vital role of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…